Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation
出版年份 2016 全文链接
标题
Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation
作者
关键词
-
出版物
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 12, Pages 4529-4534
出版商
The American Association of Immunologists
发表日期
2016-11-12
DOI
10.4049/jimmunol.1601198
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells
- (2016) Holly M. Jacobs et al. JOURNAL OF IMMUNOLOGY
- Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers
- (2015) William A. Figgett et al. JOURNAL OF AUTOIMMUNITY
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- B Lymphocyte Stimulator Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation
- (2014) S. K. Chang et al. JOURNAL OF IMMUNOLOGY
- Vaccine for Atherosclerosis
- (2014) Prediman K. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation
- (2012) Tin Kyaw et al. PLoS One
- B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions
- (2011) Tin Kyaw et al. CIRCULATION RESEARCH
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
- (2011) Deborah P. M. Symmons et al. Nature Reviews Rheumatology
- Lupus Atherosclerosis Prevention Study (LAPS)
- (2010) M. A. Petri et al. ANNALS OF THE RHEUMATIC DISEASES
- The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice
- (2010) Yanice V. Mendez-Fernandez et al. ATHEROSCLEROSIS
- B cell depletion reduces the development of atherosclerosis in mice
- (2010) Hafid Ait-Oufella et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
- (2010) Ming Zhao et al. JOURNAL OF IMMUNOLOGY
- Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis
- (2010) T. Kyaw et al. JOURNAL OF IMMUNOLOGY
- Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
- (2010) Cristina Anania et al. ARTHRITIS RESEARCH & THERAPY
- Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study
- (2009) A. Elisabeth Hak et al. ARTHRITIS AND RHEUMATISM
- Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2009) Myles J. Lewis et al. CIRCULATION
- B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation
- (2009) Yu-Hee Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development
- (2009) V.-I. Alexaki et al. JOURNAL OF IMMUNOLOGY
- BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
- (2008) J. L. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now